Ankur C. Patel

FDA investigator

Appears on 9 documents from 2021 to 2026, most often at sites in New Jersey. Most often cites automatic, mechanical, and electronic equipment (21 CFR 211.68).

9
Documents on file
4.2
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 31 observations

Activity by year

2021: 1, 2022: 1, 2023: 3, 2024: 2, 2025: 1, 2026: 1

Where

New Jersey 4 · India 1 · Japan 1 · New York 1 · North Carolina 1 · Pennsylvania 1

Is Ankur C. Patel coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Fresenius Kabi USA, LLCFeb 13, 2026 · Wilson, North Carolina
483 Endo USA, Inc.Jan 17, 2025 · Cranbury, New Jersey
483 Shiseido America Inc.Dec 3, 2024 · East Windsor, New Jersey
483 Vasudha pharma chem limitedSep 13, 2024 · Ankapalli, India
483 Eisai Company Ltd.Oct 27, 2023 · Kakamigahara, Japan
483 APPCO PHARMA LLCAug 29, 2023 · Piscataway, New Jersey
483 Chartwell Pharmaceuticals Congers, LLCMay 24, 2023 · Congers, New York

About this profile

What does Ankur C. Patel inspect?

Ankur C. Patel appears on 9 documents on file covering 9 sites, most often in New Jersey.

What do they cite most often?

21 CFR 211.68 (automatic, mechanical, and electronic equipment), followed by 21 CFR 211.22 and 21 CFR 211.111.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ankur C. Patel is dated Feb 13, 2026.